AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-5.11%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.4B
AUM Growth
-$929M
(-8.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162
Top Buys
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$46.4M |
| 2 |
Stem
STEM
|
$28.4M |
| 3 |
Plains All American Pipeline
PAA
|
$21.2M |
| 4 |
Evercore
EVR
|
$16.7M |
| 5 |
Green Plains
GPRE
|
$15.8M |
Top Sells
| 1 |
MPLX
MPLX
|
$69.9M |
| 2 |
Universal Display
OLED
|
$47.2M |
| 3 |
Acuity Brands
AYI
|
$44.9M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$40.6M |
| 5 |
Western Midstream Partners
WES
|
$39.1M |
Sector Composition
| 1 | Energy | 50.72% |
| 2 | Financials | 11.42% |
| 3 | Technology | 6.62% |
| 4 | Healthcare | 4.85% |
| 5 | Consumer Discretionary | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
176
Block, Inc.
XYZ
$45.5B
| $4.96M | 0.05% |
20,679
-995
| -5% | -$239K |
|
177
Boston Scientific
BSX
$159B
| $4.74M | 0.05% |
109,289
-363
| -0.3% | -$15.8K |
|
178
Iovance Biotherapeutics
IOVA
$876M
| $4.69M | 0.05% |
190,019
-10,411
| -5% | -$257K |
|
179
Aemetis
AMTX
$151M
| $4.62M | 0.04% |
252,585
+34,572
| +16% | +$632K |
|
180
Fidelity National Information Services
FIS
$35.9B
| $4.55M | 0.04% |
37,381
+1,246
| +3% | +$152K |
|
|
ARNA
181
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.46M | 0.04% |
74,855
-4,786
| -6% | -$285K |
|
|
KRTX
182
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.43M | 0.04% |
36,219
-2,478
| -6% | -$303K |
|
|
ETRN
183
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $4.41M | 0.04% |
435,235
-32,898
| -7% | -$334K |
|
|
IEA
184
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $4.29M | 0.04% |
375,577
+202,939
| +118% | +$2.32M |
|
|
RMO
185
DELISTED
Romeo Power, Inc.
RMO
| $4.25M | 0.04% |
859,416
+137,246
| +19% | +$679K |
|
186
Thermo Fisher Scientific
TMO
$186B
| $4.05M | 0.04% |
7,096
-263
| -4% | -$150K |
|
187
Oracle
ORCL
$652B
| $3.98M | 0.04% |
45,622
-2,577
| -5% | -$225K |
|
188
Antero Midstream
AM
$8.71B
| $3.94M | 0.04% |
378,263
-28,565
| -7% | -$298K |
|
189
Prothena Corp
PRTA
$458M
| $3.93M | 0.04% |
55,206
-2,674
| -5% | -$190K |
|
190
Salesforce
CRM
$237B
| $3.93M | 0.04% |
14,487
-2,002
| -12% | -$543K |
|
191
Eli Lilly
LLY
$654B
| $3.87M | 0.04% |
16,760
-887
| -5% | -$205K |
|
192
IAC Inc
IAC
$2.97B
| $3.87M | 0.04% |
36,216
+670
| +2% | +$71.6K |
|
193
Broadcom
AVGO
$1.57T
| $3.83M | 0.04% |
78,970
-2,150
| -3% | -$104K |
|
|
SWTX
194
DELISTED
SpringWorks Therapeutics
SWTX
| $3.82M | 0.04% |
60,214
-4,102
| -6% | -$260K |
|
195
Cytokinetics
CYTK
$6.28B
| $3.66M | 0.04% |
102,354
+7,862
| +8% | +$281K |
|
196
ALX Oncology
ALXO
$64.8M
| $3.65M | 0.04% |
49,448
-3,234
| -6% | -$239K |
|
197
Liberty Broadband Class C
LBRDK
$8.58B
| $3.55M | 0.03% |
20,550
+3,450
| +20% | +$596K |
|
198
Apellis Pharmaceuticals
APLS
$3.59B
| $3.52M | 0.03% |
106,632
+1,008
| +1% | +$33.2K |
|
199
American Superconductor
AMSC
$2.2B
| $3.49M | 0.03% |
239,081
+31,921
| +15% | +$465K |
|
200
Aurinia Pharmaceuticals
AUPH
$1.65B
| $3.48M | 0.03% |
157,076
-10,525
| -6% | -$233K |
|